ロード中...
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
DNA repair activity of malignant cells seems to influence therapeutic outcome and patients’ survival. Herein, we investigated the mechanistic basis for the link between DNA repair efficiency and response to antimyeloma therapy. Nucleotide excision repair (NER), interstrand cross-links repair (ICL/R)...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5524533/ https://ncbi.nlm.nih.gov/pubmed/27443291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-01-691618 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|